Related Experiment Videos
The expression of the ACTH receptor
1Molecular Endocrinology Laboratory, Department of Chemical Endocrinology, St. Bartholomew's and the Royal London School of Medicine and Dentistry, London, England. llelias@hotmail.com
Summary
Mutations in the adrenocorticotropic hormone receptor (ACTH-R) cause familial glucocorticoid deficiency (FGD). These ACTH-R gene defects impair the receptor's ability to bind ACTH and trigger a cellular response, leading to disease.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Adrenal glucocorticoid secretion is regulated by adrenocorticotropic hormone (ACTH) via the ACTH receptor (ACTH-R).
- ACTH-R is a G protein-coupled receptor, part of the melanocortin receptor subfamily, primarily expressed in adrenocortical cells.
- Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder linked to impaired adrenal response to ACTH.
Purpose of the Study:
- To functionally characterize mutations in the ACTH-R gene associated with familial glucocorticoid deficiency (FGD).
- To investigate the impact of these mutations on ACTH binding and intracellular signaling.
- To establish a reliable cellular system for studying ACTH-R function without background interference.
Main Methods:
- Utilized Y6 cells, a cell line lacking endogenous melanocortin receptor activity, for functional studies of human ACTH-R.
- Assessed cAMP response to ACTH stimulation in cells expressing mutated ACTH-R variants.
- Performed ACTH-binding studies to evaluate ligand affinity in the presence of mutations.
Main Results:
- Several ACTH-R mutations found in FGD patients resulted in impaired cAMP signaling or reduced sensitivity to ACTH.
- ACTH-binding studies revealed impaired ligand binding and loss of high-affinity binding sites for most mutations.
- The Y6 cell system proved effective for functional analysis of ACTH-R mutations.
Conclusions:
- Mutations in the ACTH-R gene are a significant cause of familial glucocorticoid deficiency.
- These genetic defects disrupt ACTH binding and downstream signaling pathways, leading to impaired glucocorticoid production.
- Functional characterization using engineered cell lines is crucial for understanding the molecular basis of FGD.